Gain Therapeutics (GANX) P/E (2021 - 2026)
Gain Therapeutics (GANX) P/E from Mar 18, 2021 to Jul 21, 2026. The TTM Gain Therapeutics (GANX) P/E is -3.20. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Gain Therapeutics (GANX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.20 | -40.32% |
| 2025 | -5.36 | +112.68% |
| 2024 | -2.52 | +38.58% |
| 2023 | -1.82 | -21.12% |
| 2022 | -2.30 | -50.38% |
| 2021 | -4.64 | N/A |
Comparison Gain Therapeutics (GANX) P/E with competitors
Gain Therapeutics (GANX) P/E is -3.20.